These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis]. Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470 [TBL] [Abstract][Full Text] [Related]
3. The extrinsic system. Triplett DA Clin Lab Med; 1984 Jun; 4(2):221-44. PubMed ID: 6388984 [TBL] [Abstract][Full Text] [Related]
4. Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII. Koizume S; Jin MS; Miyagi E; Hirahara F; Nakamura Y; Piao JH; Asai A; Yoshida A; Tsuchiya E; Ruf W; Miyagi Y Cancer Res; 2006 Oct; 66(19):9453-60. PubMed ID: 17018600 [TBL] [Abstract][Full Text] [Related]
5. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII. Nielsen VG; Cohen BM; Cohen E Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625 [TBL] [Abstract][Full Text] [Related]
6. Recombinant activated factor VII as a universal haemostatic agent. Hedner U Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S147-52. PubMed ID: 9819047 [TBL] [Abstract][Full Text] [Related]
7. Levels of prothrombin activation peptide F1+2 in patients with a bleeding tendency. Ingerslev J; Holm M; Christiansen K; Knudsen L; Négrier C Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S129-34. PubMed ID: 9819044 [TBL] [Abstract][Full Text] [Related]
8. Congenital bleeding disorders of the vitamin K-dependent clotting factors. Girolami A; Scandellari R; Scapin M; Vettore S Vitam Horm; 2008; 78():281-374. PubMed ID: 18374200 [TBL] [Abstract][Full Text] [Related]
9. [Activated factor VII as a new cardiovascular risk factor of atherothrombotic disease]. Kario K; Matsuo T; Miyata T Rinsho Byori; 1995 Dec; 43(12):1201-8. PubMed ID: 8569029 [TBL] [Abstract][Full Text] [Related]
10. III. Instantaneous inhibition by compound 48/80 of tissue factor-initiated extrinsic coagulation is mediated by the downregulation of factor VII activation. Chu AJ; Wang ZG; Fox MJ Arch Biochem Biophys; 2000 May; 377(2):357-65. PubMed ID: 10845714 [TBL] [Abstract][Full Text] [Related]
11. Characterization of mild coagulation factor VII deficiency: activity and clearance of the Arg315Trp and Arg315Lys variants in the Cys310-Cys329 loop (c170s). Furlan Freguia C; Toso R; Pollak ES; Arruda VR; Pinotti M; Bernardi F Haematologica; 2004 Dec; 89(12):1504-9. PubMed ID: 15590402 [TBL] [Abstract][Full Text] [Related]
12. [Factor VII, a therapeutic alternative in the treatment of severe haemoghage disorders]. Morales León V; Herrera Ortega G; Molero Gómez R; García Cortés J Farm Hosp; 2003; 27(1):38-41. PubMed ID: 12607015 [TBL] [Abstract][Full Text] [Related]
13. Establishment of a cell line expressing recombinant factor VII and its subsequent conversion to active form FVIIa through hepsin by genetic engineering method. Halabian R; Roudkenar MH; Esmaeili NS; Masroori N; Roushandeh AM; Najafabadi AJ Vox Sang; 2009 May; 96(4):309-15. PubMed ID: 19175565 [TBL] [Abstract][Full Text] [Related]
14. Use of recombinant factor VII in hepatology. Romero Castro R; Barroso Relinque N; Caunedo Alvarez A; García Montes JM; Herrerías Gutiérrez JM Rev Esp Enferm Dig; 2001 Oct; 93(10):659-68. PubMed ID: 11767490 [TBL] [Abstract][Full Text] [Related]
15. Influence of warfarin therapy on activated factor VII clotting activity. Lippi G; Montagnana M; Salvagno GL; Poli G; Franchini M; Guidi GC Blood Coagul Fibrinolysis; 2006 Apr; 17(3):221-4. PubMed ID: 16575262 [TBL] [Abstract][Full Text] [Related]
16. Analysis of biological phenotypes from 42 patients with inherited factor VII deficiency: can biological tests predict the bleeding risk? Giansily-Blaizot M; Verdier R; Biron-Adréani C; Schved JF; Bertrand MA; Borg JY; Le Cam-Duchez V; Briquel ME; Chambost H; Pouymayou K; Dutrillaux F; Favier R; Martin-Toutain I; Verdy E; Gay V; Goudemand J; Navarro R; Durin A; d'Oiron R; Lambert T; Pernod G; Barrot C; Peynet J; Bastenaire B; Sie P; Stieltjes N; Torchet MF; de Moerloose P; Haematologica; 2004 Jun; 89(6):704-9. PubMed ID: 15194538 [TBL] [Abstract][Full Text] [Related]
17. Two independent binding sites on monolayers of human endothelial cells are responsible for interaction with coagulation factor VII and factor VIIa. Reuning U; Preissner KT; Müller-Berghaus G Thromb Haemost; 1993 Feb; 69(2):197-204. PubMed ID: 8456434 [TBL] [Abstract][Full Text] [Related]
18. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels. Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067 [TBL] [Abstract][Full Text] [Related]
19. The interaction between platelets and factor VII/VIIa. Lau HK Transfus Apher Sci; 2003 Jun; 28(3):279-83. PubMed ID: 12725955 [TBL] [Abstract][Full Text] [Related]